title: The gp120-CD4 interface: structural, immunological and pathological considerations.
authors.affiliation: IDEC Pharmaceuticals Corporation, La Jolla, CA 92037.
authors.forename: T
authors.initials: T
authors.lastname: Kieber-Emmons
authors.forename: B A
authors.initials: BA
authors.lastname: Jameson
authors.forename: W J
authors.initials: WJ
authors.lastname: Morrow
mesh_terms: D000595:Amino Acid Sequence; D001665:Binding Sites; D015704:CD4 Antigens / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D006031:Glycosylation; D015699:HIV Envelope Protein gp120 / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D015658:HIV Infections / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008969:Molecular Sequence Data; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D007136:Immunoglobulins; D014765:Viral Vaccines